ATTRV30M amyloidosis

Get in touch with RARE Concierge.

Contact RARE Concierge

ATTRV30M amyloidosis

Synonyms: ATTRV30M-related amyloidosis | Hereditary ATTRV30M-related amyloidosis

A rare hereditary ATTR amyloidosis (hATTR) characterized by a progressive length-dependent sensorimotor axonal polyneuropathy and/or autonomic neuropathy in adulthood. Renal ocular and cardiac involvement also frequently occurs. Two different phenotypes are associated with this mutation namely early-onset V30M and late-onset V30M that differ in terms of age on onset (50 years respectively) presenting features histopathological characteristics rate of disease progression and response to therapy.

Data from Orphanet are used to provide information on a disease's name, synonym(s), and overview.

Reference: Access aggregated data from Orphanet at Orphadata.

Orphadata: Free access data from Orphanet. © INSERM 1999. Available on http://www.orphadata.org. Data version March 2024

Newly diagnosed with
ATTRV30M amyloidosis?

Our RARE Concierge Services Guides are available to assist you by providing information, resources and connections as you navigate your rare disease journey.

Get Concierge Help

Advocacy Organizations

My Faulty Gene

My Faulty Gene is a nonprofit organization which provides information and assistance to any individual whose family medical history suggests genetic testing might be helpful in identifying an increased risk of disease due to a genetic mutation. We believe that everyone in need of genetic testing should have access to it.

New Zealand Amyloidosis Patients Association

To make a positive and lasting impact in New Zealand, helping Amyloidosis disease patients from various disease subgroups ( AL, AA, hATTR, Wild Type) by working with local and international doctors, pharma treatment entities, as well as government agencies to bring approved funded treatment drugs into NZ for suffering patients. We desire to help build a lasting support system within the NZ health framework. We want an excellent wrap-around network of care to achieve for the sufferer to achieve a positive outcome in their well-being. This mission includes the wellness of the patient's caregiver and family whose needs, we feel, have been neglected.

Clinical Trials

For a list of clinical trials in this disease area, please click here.